METHODS: Indium-111 activity concentrations in human tumor and normal tissue samples were determined at 24, 48 and 120 hr after i.v. injection of 111In-DTPA-D-Phe-1-octreotide. Fourteen patients were included in the study. Seven patients had medullary thyroid carcinoma, four had midgut carcinoid tumors, two had endocrine pancreatic tumors and one had chronic pancreatitis. RESULTS: For midgut carcinoids, the tumor-to-blood ratio was 51:220, for medullary thyroid carcinoma 4:39, and for two endocrine pancreatic tumors 6 and 1500. Tumor-to-muscle ratios varied between 1 and 1200 and tumor-to-fat between 2 and 1500 depending on tumor type. CONCLUSION: The sometimes extremely high tumor-to-normal tissue ratios present the possibility for use of radiolabeled octreotide for radiation therapy of somatostatin receptor positive tumors.
METHODS:Indium-111 activity concentrations in humantumor and normal tissue samples were determined at 24, 48 and 120 hr after i.v. injection of 111In-DTPA-D-Phe-1-octreotide. Fourteen patients were included in the study. Seven patients had medullary thyroid carcinoma, four had midgut carcinoid tumors, two had endocrine pancreatic tumors and one had chronic pancreatitis. RESULTS: For midgut carcinoids, the tumor-to-blood ratio was 51:220, for medullary thyroid carcinoma 4:39, and for two endocrine pancreatic tumors 6 and 1500. Tumor-to-muscle ratios varied between 1 and 1200 and tumor-to-fat between 2 and 1500 depending on tumor type. CONCLUSION: The sometimes extremely high tumor-to-normal tissue ratios present the possibility for use of radiolabeled octreotide for radiation therapy of somatostatin receptor positive tumors.
Authors: L Kölby; P Bernhardt; H Ahlman; B Wängberg; V Johanson; A Wigander; E Forssell-Aronsson; S Karlsson; B Ahrén; G Stenman; O Nilsson Journal: Am J Pathol Date: 2001-02 Impact factor: 4.307
Authors: Christina Swärd; Peter Bernhardt; Håkan Ahlman; Bo Wängberg; Eva Forssell-Aronsson; Maria Larsson; Johanna Svensson; Rauni Rossi-Norrlund; Lars Kölby Journal: World J Surg Date: 2010-06 Impact factor: 3.352
Authors: O Nilsson; L Kölby; B Wängberg; A Wigander; H Billig; L William-Olsson; M Fjälling; E Forssell-Aronsson; H Ahlman Journal: Br J Cancer Date: 1998-02 Impact factor: 7.640
Authors: L Kölby; P Bernhardt; V Johanson; A Schmitt; H Ahlman; E Forssell-Aronsson; H Mäcke; O Nilsson Journal: Br J Cancer Date: 2005-11-14 Impact factor: 7.640
Authors: L E Tisell; H Ahlman; B Wängberg; L Kölby; M Fjälling; E Forssell-Aronsson; J Mölne; O Nilsson Journal: Br J Cancer Date: 1999-03 Impact factor: 7.640
Authors: L Kölby; P Bernhardt; A-M Levin-Jakobsen; V Johanson; B Wängberg; H Ahlman; E Forssell-Aronsson; O Nilsson Journal: Br J Cancer Date: 2003-10-06 Impact factor: 7.640